These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
670 related articles for article (PubMed ID: 26024755)
1. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease. Ganji SH; Kashyap ML; Kamanna VS Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885 [TBL] [Abstract][Full Text] [Related]
3. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]
4. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887 [TBL] [Abstract][Full Text] [Related]
5. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Joshi-Barve S; Barve SS; Amancherla K; Gobejishvili L; Hill D; Cave M; Hote P; McClain CJ Hepatology; 2007 Sep; 46(3):823-30. PubMed ID: 17680645 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles. Vesterdal LK; Danielsen PH; Folkmann JK; Jespersen LF; Aguilar-Pelaez K; Roursgaard M; Loft S; Møller P Toxicol Appl Pharmacol; 2014 Jan; 274(2):350-60. PubMed ID: 24121055 [TBL] [Abstract][Full Text] [Related]
7. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023 [TBL] [Abstract][Full Text] [Related]
8. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling. Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396 [TBL] [Abstract][Full Text] [Related]
9. Hesperetin ameliorates hepatic oxidative stress and inflammation Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953 [TBL] [Abstract][Full Text] [Related]
10. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress. Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305 [TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171 [TBL] [Abstract][Full Text] [Related]
13. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620 [TBL] [Abstract][Full Text] [Related]
15. Niacin for treatment of nonalcoholic fatty liver disease (NAFLD): novel use for an old drug? Kashyap ML; Ganji S; Nakra NK; Kamanna VS J Clin Lipidol; 2019; 13(6):873-879. PubMed ID: 31706905 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis. Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway. Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914 [TBL] [Abstract][Full Text] [Related]
18. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress. Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease. Lakhani HV; Sharma D; Dodrill MW; Nawab A; Sharma N; Cottrill CL; Shapiro JI; Sodhi K Int J Med Sci; 2018; 15(14):1591-1599. PubMed ID: 30588181 [TBL] [Abstract][Full Text] [Related]
20. Gallic Acid Inhibits Lipid Accumulation via AMPK Pathway and Suppresses Apoptosis and Macrophage-Mediated Inflammation in Hepatocytes. Tanaka M; Sato A; Kishimoto Y; Mabashi-Asazuma H; Kondo K; Iida K Nutrients; 2020 May; 12(5):. PubMed ID: 32443660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]